Trillium Therapeutics Inc.

(TRIL) Trade

By |

Profile

Trillium Therapeutics Inc is an immuno-oncology company developing therapies for the treatment of cancer. Its SIRPaFc and CD200 monoclonal antibody targets immuno regulatory pathways that tumor cells exploit to evade the host immune system.

Contact Information

Website: www.trilliumtherapeutics.com
Email: mark@canalecomm.com
Main Phone: +1 416 595-0627
Address: 2488 Dunwin Drive
State: ON
City / Town: Mississauga
Country: CAN
Postal Code: L5L 1J9

Issuer Information

Exchange: NSC
CEO: Niclas Stiernholm
Employees: 59
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 5.95 $ -0.15 (-2.46%)
Last Price 5.95 Change $ -0.15 Change % -2.46 Tick N/A
Bid 5.95 Bid Size 100.00 Ask 6.75 Ask Size 600.00
Open 6.05 High 6.25 Low 5.94 Prev Close 6.10
Last Trade Volume 70,110 52 Wk Hi 13.30 52 Wk Low 4.75
Market Cap 85.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 14,424,498.00 EPS (TTM) N/A PE Ratio N/A Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 18 18 18 18
Low Target Price Estimate 7 7 7 7
Mean Target Price Estimate 10.92 10.92 10.92 10.92
Standard Deviation 6.14 6.14 6.14 6.14
Date of Most Recent Estimate 05/25/18 05/25/18 05/25/18 05/25/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 1 1 1 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.4 1.4 1.4 1